<code id='AE3D61C405'></code><style id='AE3D61C405'></style>
    • <acronym id='AE3D61C405'></acronym>
      <center id='AE3D61C405'><center id='AE3D61C405'><tfoot id='AE3D61C405'></tfoot></center><abbr id='AE3D61C405'><dir id='AE3D61C405'><tfoot id='AE3D61C405'></tfoot><noframes id='AE3D61C405'>

    • <optgroup id='AE3D61C405'><strike id='AE3D61C405'><sup id='AE3D61C405'></sup></strike><code id='AE3D61C405'></code></optgroup>
        1. <b id='AE3D61C405'><label id='AE3D61C405'><select id='AE3D61C405'><dt id='AE3D61C405'><span id='AE3D61C405'></span></dt></select></label></b><u id='AE3D61C405'></u>
          <i id='AE3D61C405'><strike id='AE3D61C405'><tt id='AE3D61C405'><pre id='AE3D61C405'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:773
          Gavel and Stethoscope due process
          District courts will make the first round of decisions soon on challenges to Medicare's drug price negotiation program. APStock

          WASHINGTON — Pharmaceutical companies’ efforts to scuttle President Biden’s signature health care achievement, empowering Medicare to negotiate prescription drug prices, will soon face their first big tests.

          District court judges could soon weigh in on the litany of court cases that major companies filed against the government — shedding light on whether drugmakers have any hope of postponing the first parts of the negotiation process, scrapping it entirely, or sending the issue up to the Supreme Court.

          advertisement

          It’s a major moment for the Biden administration, too, as the White House ramps up its efforts to take credit for the new changes in the 2024 election. The first round of legal decisions will play out in the thick of campaign season, attorneys told STAT.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Stroke rates rising, especially in working
          Stroke rates rising, especially in working

          AdobeStrokeprevalencehasbeenclimbingoverthepastdecade,reversingasteadydeclineamongallAmericanswhiler

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          Being 'nonadherent' patient made me a more empathetic doctor

          AdobeWhenIwas13yearsold,Ihadtotake11pillseveryday.Ihadnon-Hodgkin’slymphoma,andthesepillsworkedeithe